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Abstract Background Decreased large artery function, as reflected by increased brachial artery
pulse pressure and increased carotid artery diameter and stiffness, may contribute to the
increased mortality risk that is observed in subjects with impaired glucose tolerance. We
therefore investigated the association between brachial artery pulse pressure and carotid
artery diameter and stiffness, which are estimates of central artery stiffness and arterial
remodelling, respectively, and mortality in subjects with a recent history of impaired
glucose tolerance.
Design A prospective, population-based cohort study. We measured brachial artery pulse
pressure by oscillometric blood pressure measurements, and common carotid artery
diameter and distensibility and compliance coefficients by ultrasound in 140 subjects with a
recent history of impaired glucose tolerance. During a median 6·6-year follow-up, 16
subjects died.
Results Brachial artery pulse pressure and common carotid artery diameter were positively
related to all-cause mortality [hazard ratios per standard deviation, 1·7 (1·2–2·5) and 2·1
(1·3–3·3), respectively]. Results were similar after adjustment for gender, age, waist-to-hip
ratio, body mass index, total cholesterol concentration, pre-existent cardiovascular disease,
and hypertension, and after additional mutual adjustment. Common carotid artery
distensibility and compliance coefficients were not statistically significantly associated with
mortality.
Conclusions Among subjects with a recent history of impaired glucose tolerance, brachial
artery pulse pressure and common carotid artery diameter are independently associated
with mortality risk. Stiffness of the central arteries may explain the association between
pulse pressure and mortality risk. The association between carotid diameter and mortality
risk is more likely to reflect arterial remodelling in response to atherosclerosis than that in
response to increased local stiffness.
Keywords common carotid artery diameter, common carotid artery stiffness, impaired
glucose tolerance, mortality, pulse pressure.
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Introduction
Cardiovascular risk factors cluster in subjects with
impaired glucose tolerance or type 2 diabetes mellitus
[1,2], which results in a risk of cardiovascular disease that
is considerably higher than that in subjects with normal
glucose tolerance [1,3]. This clustering of cardiovascular
risk factors is thought to induce adverse changes in arterial
structure and function, which then predispose to clinical
atherothrombotic disease.
In subjects with normal glucose tolerance, a large
brachial artery pulse pressure [4–10] and an enlarged
carotid artery diameter are associated with an adverse
cardiovascular prognosis [11], suggesting that these
alterations in arterial function and structure are relevant
to the pathogenesis of clinical atherothrombotic disease.
More specifically, brachial artery pulse pressure is thought
to reflect stiffness of the central arteries, and enlarged
carotid artery diameter is one of the manifestations of
arterial remodelling (i.e. a change in structural and
functional arterial properties through time due to exposure
to an adverse metabolic and/or biophysical environment)
[12]. Indeed, increased central arterial stiffness is asso-
ciated with increased cardiac afterload [13,14] and
decreased coronary artery filling pressure [15], which
may explain the association of brachial artery pulse
pressure with mortality [4–10]. In turn, at least two
processes may be involved in arterial diameter enlargement
due to remodelling and may explain the association of a
large arterial diameter with mortality [11]. First, diameter
enlargement occurs in atherosclerosis, either locally, in
order to maintain free lumen area in arterial segments in
which intima-media thickness is increased [16] (a sign of
atherosclerosis in progress) or in which an atherosclerotic
plaque is present [17], or as part of a more generalized
phenomenon [16]. Second, arterial diameter enlargement
often occurs hand in hand with an increase in local
stiffness [18–20], possibly to maintain local compliance
(i.e. the capacity of the artery to buffer pulsatile blood flow
[21]).
In subjects with impaired glucose tolerance, arterial
stiffness is increased as compared to subjects with
normal glucose tolerance [22]. In addition, carotid
arterial diameter enlargement occurs in relation to
blood pressure level and plasma glucose concentration,
suggesting arterial remodelling [19]. However, it is not
known whether these estimates of altered arterial
function and structure are associated with an adverse
prognosis in subjects with impaired glucose tolerance.
Because, as explained above, arterial remodelling may be
related to increased local arterial stiffness, it is con-
ceivable that increased arterial stiffness and arterial
remodelling affect prognosis through the same pathway,
and are therefore not independently associated with an
adverse prognosis.
To study these issues, we measured brachial artery pulse
pressure and common carotid artery diameter and stiffness
in 140 subjects with a recent history of impaired glucose
tolerance, and investigated whether these estimates of
arterial function and structure were associated with risk of
mortality during a 6·6-year follow-up.
Methods
Study population and overall design
The present study comprises part of the Hoorn Study, a
population-based cohort study of diabetes and cardiovas-
cular disease in which 2484 Caucasian men and women
born between 1914 and 1940 participated. The study
population, research design, laboratory methods and
anthropometric measurements have been described in
detail previously [19,23,24]. In brief, an age-, gender- and
glucose-tolerance-stratified sample of 708 subjects was
invited for additional extensive investigations; 631 subjects
(89%) agreed and participated in the follow-up of the
study. Of these 631, 224 had impaired glucose tolerance
according to the average of two oral glucose tolerance tests
(1985 WHO criteria [25]), in which samples were taken in
the fasting state (between 08·30 h and 09·30 h after a 10-h
fast) and 120 min after a 75-g glucose load [25]. Of the
subjects with impaired glucose tolerance, 140 (63%)
agreed to undergo ultrasonography of the common carotid
artery combined with blood pressure measurements,
which took place 2·3 years (median 25–75%: 2·0–
2·7 years; between January and October 1993) after the
diagnosis of impaired glucose tolerance. (Two more
follow-up common carotid artery examinations were
conducted and have been described elsewhere [19].) We
obtained metabolic and anthropometric measurements
6·0 weeks (median; 25–75%: 4–13 weeks) before the
common carotid artery examination. We shall refer to
these 1993 measurements as ‘baseline’. Subjects were then
followed until January 2000 (median follow-up duration
6·6 years; interquartile range: 6·6–6·7). Dates of death
were extracted from the population register of the city of
Hoorn or from the population registers of the cities to
which the subjects had moved.
Measurement of common carotid artery diameter
Common carotid artery diameter was determined using an
ultrasound system (Ultramark IV, ATL, Bothell, WA) in
combination with a vessel wall movement detector system
[26] (Wall Track System, Neurodata, Bilthoven, the
Netherlands). All subjects refrained from smoking or
consuming caffeine for at least 4 h before the examination.
Measurements were carried out by a single experienced
ultrasound technician in a quiet room after the subjects
had rested for 15 min in the supine position. After
localization of the common carotid artery, a cross-section
was selected for diameter measurement approximately
10 mm proximal to the carotid bulb. Sites with mural
atherosclerotic plaques were avoided. Each recording
lasted 4 s; this enabled continuous recording of the arterial
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diameter for several heart beats. Recordings were ECG-
triggered to maximizing the number of heart beats in this
period and were repeated if the diastolic diameter or the
difference between systolic and diastolic diameter (disten-
sion; see below) showed a standard deviation of more than
10%.
Blood pressure measurement
The systolic, mean and diastolic blood pressures were
recorded at the level of the left brachial artery at 5-min
intervals using an oscillometric blood pressure measuring
device (Col, in press-Mate BP-8800, Colin, Komaki-City,
Japan). Pulse pressure was defined as systolic minus
diastolic blood pressure. The mean of all blood pressure
measurements during the actual ultrasonography (median:
3) was used in the statistical analyses. Subjects were
regarded as hypertensive if their systolic blood pressure
was $ 160 mmHg, if their diastolic blood pressure was
$ 95 mmHg and/or if they used antihypertensive medica-
tion.
Definition of arterial properties
Common carotid artery diameter (in mm) was defined as
mean diastolic diameter of three recordings, common
carotid artery distension (in mm) as mean difference
between systolic and diastolic diameters. The distensibility
coefficient was calculated as [(2  distension)/(diameter
 pulse pressure  0·1333)] (in Pa21), and the cross-
sectional compliance coefficient as (p  diameter)  [dis-
tension/(266·6  pulse pressure)] (in mm2 kPa21)
[20,27,28]. Pulse pressure was not calculated from
common carotid, but from brachial artery blood pressure,
which has been shown to provide a relatively good
approximation [19,27]. The distensibility and the com-
pliance coefficients are indices of elasticity and therefore
inversely related to stiffness. The distensibility coefficient
describes intrinsic vessel wall stiffness, while the compli-
ance coefficient is a measure of the capacity of the vessel to
buffer the pulsatile blood flow.
Reproducibility
The intrameasurement variability (coefficient of variation)
in the three ultrasound recordings of one measurement of
the carotid diameter was 1·0%. The variability between
two measurements conducted on the same day by the
same observer (coefficient of variation) was 1·5% for the
diameter, 4·2% for the distensibility coefficient and 2·1%
for the compliance coefficient.
Statistical analysis
Data were expressed as mean (standard deviation) or as
median (interquartile range), the latter for variables
without a normal distribution. Student’s t-test was used
to examine differences between drop-outs and partici-
pants, and between those who died and those who did not.
Variables without a normal distribution were logarithmi-
cally transformed before they were entered in Student’s
t-test (but in the tables their untransformed values are
shown). The Mann–Whitney test was used for variables
without a normal distribution after logarithmic transfor-
mation. The x2 test was used for comparing gender,
smoking habits, glucose tolerance category, pre-existent
cardiovascular disease and hypertensive status between
groups. Cox’s proportional hazards regression analysis was
used to investigate the association of clinical, biochemical
and haemodynamic variables with mortality, focusing on
brachial artery pulse pressure and common carotid artery
diameter, distensibility coefficient and compliance coeffi-
cient as key independent variables. We employed four
models. In the first model, no adjustments were made
(univariate). In the second model, adjustments were made
for age and sex. In the third model, we added independent
variables that were univariately associated with mortality
with P , 0·10, except that we did not adjust the
association between pulse pressure and mortality for
systolic blood pressure or the presence of hypertension,
because these variables are closely related to pulse
pressure. Instead, we did analyses without and with
adjustment for mean arterial pressure, the latter to obtain
an estimate of the association between pulse pressure (i.e.
arterial stiffness) and mortality independent of the increase
in stiffness due to increased blood pressure per se [29]. In
the fourth model, adjustments were made only for carotid
artery diameter (in analyses that focused on brachial pulse
pressure) or for brachial pulse pressure (in analyses that
focused on carotid artery diameter), in order to investigate
whether any association between brachial artery pulse
pressure and mortality was mediated through carotid
diameter (assumed to reflect arterial remodelling), and
whether any association between carotid artery diameter
and mortality was mediated through brachial artery pulse
pressure (assumed to reflect central arterial stiffness).
(Adjustments for brachial artery pulse pressure or for
common carotid artery diameter were not possible in
analyses with carotid artery distensibility or compliance
coefficients as key independent variables, as these were
calculated using pulse pressure and diameter.) Results of
Cox’s regression analyses are shown per standard deviation
of the independent variable.
Probability values , 0·05 were considered to be
statistically significant. SPSS (SPSS for Windows, version
9·0, SPSS Inc., Chicago, IL) was used for all analyses.
Results
Patient characteristics
Table 1 shows the baseline clinical characteristics of the
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study population. Participants (n  140) had higher
fasting and postload glucose levels at the time of diagnosis
of impaired glucose tolerance than did those who did not
participate [n  84; 6·1 ^ 0·7 vs. 5·9 ^ 0·6 (P  0·02)
and 9·3 ^ 1·5 vs. 8·7 ^ 0·8 mmol L21 (P , 0·001),
respectively (mean ^SD)], while blood pressure, lipid
levels and other clinical data were not different (data not
shown).
During the course of the follow-up 16 subjects died. At
baseline, those who died, as compared to survivors, were
5·3 years older (P  0·01), had a lower total cholesterol
concentration (difference 0·7 mmol L21; P  0·02), but
had a higher pulse pressure (difference 11 mmHg;
P  0·003), and a 0·65-mm larger carotid artery diameter
(P  0·001; Table 1). Baseline carotid artery distensibility
and compliance coefficients did not differ significantly
between those who died and those who survived (Table 1).
Determinants of mortality
In univariate analyses, variables significantly associated
with mortality risk were age, waist-to-hip ratio, total serum
cholesterol concentration (negatively), the presence of
hypertension, systolic blood pressure, brachial artery pulse
pressure and common carotid artery diameter (Table 2,
model 1). After adjustment for age and gender, variables
significantly associated with mortality risk were total
cholesterol (negatively), the presence of hypertension,
pulse pressure and common carotid artery diameter
(Table 2, model 2).
In multivariate analyses with brachial artery pulse
pressure as key independent variable, further adjustment
for waist-to-hip ratio, body mass index, total cholesterol
concentration and pre-existent cardiovascular disease
(Table 3, model 3a), and mean arterial pressure
(Table 3, model 3b) did not materially change the point
estimate of the association between pulse pressure and
mortality, which was also the case after separate adjust-
ment for these variables. Additional adjustment for
smoking in model 3 also had no major effect on the
association (data not shown). Adjustment for carotid
artery diameter only (Table 3, model 4) somewhat lowered
the point estimate of the association between pulse
pressure and mortality, which was not materially altered
after further adjustment for age and sex (data not shown).
Table 1 Baseline characteristics among 140 subjects with a recent history of impaired glucose tolerance, according to prognosis
Survived
(n  124)
Died
(n  16)
P
n (men/women) 52/72 9/7 0·28
Age (years) 65·5 (59·5–71·8) 74·4 (63·7–76·2) 0·01
Cigarette smoking (yes/no) 67/57 5/11 0·09
Fasting serum glucose (mmol L21) 6·5 ^ 0·8 6·5 ^ 0·6 0·83
2 h postload serum glucose (mmol L21)* 9·9 ^ 2·6 10·6 ^ 2·3 0·31
Fasting serum insulin (pmol L21) 74·3 (47·2–121·5) 96·4 (69·1–158·5) 0·17
HbA1c (%) 5·7 ^ 0·6 5·8 ^ 0·5 0·79
NGT/IGT/type 2 DM/unknown21† (n) 19/63/40/2 3/5/7/1 0·40
Waist-to-hip ratio 0·90 ^ 0·08 0·95 ^ 0·12 0·03
Body mass index (kg m22) 27·7 ^ 3·5 29·3 ^ 3·2 0·09
Total cholesterol (mmol L21) 6·5 ^ 1·3 5·8 ^ 1·0 0·02
LDL-cholesterol (mmol L21) 4·6 ^ 1·2 4·1 ^ 1·0) 0·14
HDL-cholesterol (mmol L21) 1·11 (0·96–1·33) 1·10 (0·94–1·24) 0·72
Triglycerides (mmol L21) 1·7 (1·3–2·5) 1·6 (1·3–2·3) 0·38
Pre-existent cardiovascular disease‡ (yes/no) 17/107 5/11 0·07
Hypertensive§ (yes/no) 43/81 10/6 0·03
Systolic blood pressure (mmHg) 143 ^ 21 154 ^ 25 0·05
Mean arterial pressure (mmHg) 103 ^ 14 108 ^ 16 0·13
Diastolic blood pressure (mmHg) 79 ^ 11 80 ^ 11 0·82
Heart rate (beats min21) 69 ^ 12 72 ^ 16 0·41
Pulse pressure (mmHg) 63 ^ 13 74 ^ 18 0·003
Common carotid artery properties
Diameter (mm) 6·92 ^ 0·73 7·57 ^ 0·91 0·001
Distensibility coefficient (Pa21) 11·4 ^ 3·8 10·3 ^ 5·0 0·30
Compliance coefficient (mm2 kPa21) 0·43 ^ 0·17 0·47 ^ 0·27 0·46
Continuous variables are expressed as mean ^ SD or as median (interquartile range).
*Two hours after a 75-g glucose load following overnight fasting; † according to the 1985 WHO criteria for glucose tolerance [25]; ‡
self-reported peripheral arterial disease, stroke, transient ischaemic attack, angina pectoris, myocardial infarction, coronary bypass
grafting or angioplasty, and/or abnormal resting electrocardiogram (Minnesota codes 1–1 or 1–2)); § systolic blood pressure $
160 mmHg and/or diastolic blood pressure $ 95 mmHg and/or using antihypertensive medication.
NGT, normal glucose tolerance; IGT, impaired glucose tolerance; DM, diabetes mellitus; LDL, low-density lipoprotein; HDL, high-
density lipoprotein.
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In multivariate analyses with carotid artery diameter as
key independent variable, further adjustment for waist-to-
hip ratio, body mass index, total cholesterol concentration
and pre-existing cardiovascular disease (Table 3, model 3a),
and mean arterial pressure (Table 3, model 3b) somewhat
lowered the point estimate of the association between
carotid diameter and mortality. We then separately entered
each of the variables of model 3 into model 2 and found that
total cholesterol concentration, body mass index, waist-to-
hip ratio, mean arterial pressure and pre-existent cardio-
vascular disease (from largest to smallest magnitude of the
effect) all contributed to the result of model 3. In addition,
we adjusted model 3b for systolic blood pressure or the
presence of hypertension instead of mean arterial pressure,
but this gave similar results. Additional adjustment for
cigarette smoking somewhat increased the point estimate of
the association between carotid artery diameter and
mortality (model 3a: hazard ratio, 2·1 (1·3–3·5); model
3b: hazard ratio, 2·0 (1·2–3·4)). Adjustment for pulse
pressure only (Table 3, model 4) somewhat lowered the
point estimate of the association between carotid diameter
and mortality, which was not materially altered after further
adjustment for age and sex (data not shown).
After adjustment for the same variables as in the pulse
pressure or diameter analyses, neither the carotid disten-
sibility coefficient nor the carotid compliance coefficient
were statistically significantly associated with mortality
(data not shown).
Discussion
We determined brachial artery pulse pressure and com-
mon carotid artery diameter and stiffness in 140 middle-
aged and elderly subjects with a recent history of impaired
glucose tolerance, and assessed the associations of these
indices of vascular function and structure with risk of
mortality during 6·6 years of follow-up. There were four
main findings. First, a higher brachial artery pulse pressure
at baseline (thought to reflect central arterial stiffness) was
associated with an increased mortality risk [hazard ratio
Table 2 Determinants of mortality during a 6·6-year follow-up among 140 subjects with a recent history of impaired glucose tolerance
Hazard ratio Hazard ratio
(95% CI)
Model 1 P
(95% CI)
Model 2 P
Gender (0  male, 1  female) 0·8 (0·5–1·2) 0·26 0·7 (0·4–1·1) 0·11
Age 2·1 (1·2–3·9) 0·01 2·3 (1·3–4·3) 0·01
Cigarette smoking (0  no, 1  yes) 0·6 (0·4–1·1) 0·11 0·6 (0·3–1·0) 0·06
Fasting serum glucose 1·0 (0·6–1·6) 0·88 0·9 (0·5–1·6) 0·73
2 h postload serum glucose 1·2 (0·8–1·9) 0·33 1·2 (0·7–2·0) 0·49
Fasting serum insulin 1·3 (0·9–2·0) 0·20 1·2 (0·7–1·8) 0·52
HbA1c (%) 1·1 (0·7–1·7) 0·80 1·0 (0·6–1·6) 0·91
Glucose tolerance category* 1·2 (0·7–2·0) 0·58 1·0 (0·6–1·7) 0·90
Waist-to-hip ratio 1·6 (1·03–2·6) 0·04 1·4 (0·8–2·2) 0·21
Body mass index 1·5 (0·9–2·0) 0·096 1·6 (1·0–2·5) 0·07
Total cholesterol 0·6 (0·3–0·9) 0·02 0·6 (0·3–0·95) 0·03
LDL-cholesterol 0·7 (0·4–1·1) 0·16 0·7 (0·4–1·1) 0·11
HDL-cholesterol 0·9 (0·5–1·5) 0·63 1·0 (0·6–1·7) 0·99
Triglycerides 0·7 (0·4–1·4) 0·31 0·8 (0·4–1·6) 0·46
Pre-existent cardiovascular disease (0  no, 1  yes) 1·4 (0·9–2·0) 0·09 1·3 (0·9–2·0) 0·13
Hypertensive (0  no, 1  yes) 1·7 (1·02–2·8) 0·04 1·8 (1·04–2·9) 0·03
Systolic blood pressure 1·5 (1·004–2·2) 0·048 1·5 (0·9–2·4) 0·09
Mean arterial pressure 1·4 (0·9–2·2) 0·12 1·4 (0·8–2·2) 0·21
Diastolic blood pressure 1·1 (0·7–1·7) 0·78 1·1 (0·6–1·9) 0·76
Heart rate 1·2 (0·8–2·0) 0·39 1·2 (0·8–2·0) 0·36
Pulse pressure† 1·7 (1·2–2·5) 0·004 1·6 (1·1–2·5) 0·02
Common carotid artery properties:
Diameter‡ 2·1 (1·3–3·3) 0·002 2·0 (1·3–3·3) 0·004
Distensibility coefficient 0·8 (0·4–1·3) 0·30 0·9 (0·5–1·7) 0·72
Compliance coefficient 1·2 (0·8–1·9) 0·45 1·5 (0·9–2·4) 0·21
Results of proportional hazards regression analyses are shown as hazard ratios and 95% confidence intervals per standard deviation of
the independent variables. P, probability value. Adjustments: model 1: none (univariate); model 2: for age and gender. Associations with
P , 0·05 are shown in boldface.
*According to the 1985 WHO criteria for glucose tolerance [25] (0, normal glucose tolerance; 1, impaired glucose tolerance; 2, type 2
diabetes mellitus).
† standard deviation, 14 mmHg.
‡ standard deviation, 0·78 mm.
LDL, low-density lipoprotein; HDL, high-density lipoprotein.
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per standard deviation of pulse pressure (14 mmHg), 1·7
(1·2–2·5)]. Second, a larger common carotid artery
diameter at baseline (thought to reflect arterial remodel-
ling) was also associated with an increased mortality risk
[hazard ratio per standard deviation of diameter
(0·78 mm), 2·1 (1·3–3·3)]. Third, these associations
were largely independent of each other, which suggests
that the pathways linking pulse pressure and carotid
diameter to mortality differ to an important extent.
Fourth, carotid artery distensibility and compliance
coefficients, which are commonly used as measures of
local arterial stiffness, were not significantly associated
with mortality risk. We also found negative associations
between, on the one hand, total cholesterol concentration
and (self-reported) cigarette smoking and, on the other,
mortality. However, since low-density lipoprotein choles-
terol concentration, more directly linked to disturbance of
lipid metabolism than total cholesterol concentration, was
not associated with mortality, this argues against an actual
negative association of a disturbed lipid metabolism with
mortality. Intrinsic imprecision of self-reported smoking
habits may have played a role in our findings with regard to
cigarette smoking. Taken together, our main results
suggest that both central arterial stiffness and arterial
remodelling, as far as they are reflected by brachial artery
pulse pressure and carotid artery diameter, respectively,
may be relevant to understanding the increased cardiovas-
cular mortality risk in subjects with impaired glucose
tolerance (and, by extension, in patients with type 2
diabetes), and that the pathway linking carotid arterial
remodelling to mortality is more likely to involve a
response to atherosclerosis than to arterial stiffening.
Brachial artery pulse pressure was a determinant of
mortality in individuals with a recent history of impaired
glucose tolerance after adjustment for age and sex, which
is consistent with reports linking pulse pressure with
cardiovascular mortality [4–8] in the general population.
The association between pulse pressure and mortality was
no longer significant after further adjustment for multiple
cardiovascular risk factors including mean arterial pressure
(Table 3), but it should be noted that this may, in part, be
caused by overadjustment as increased pulse pressure may
be an intermediary in the pathway linking cardiovascular
risk factors with mortality. Increased brachial artery pulse
pressure is a sign of stiffening of arteries involved in
buffering the pulsatile blood flow [4–10], i.e. the aorta, in
particular the ascending aorta and the aortic arch [30], but
also the abdominal aorta and its proximal elastic branches.
Stiffening of these arteries not only decreases their
buffering capacity; it is also responsible for an increased
pressure load imposed upon the left ventricle caused by an
earlier return of reflected pulse waves [13]. Both phenom-
ena cause central blood pressure to increase during systole
and to decrease during diastole. The former is associated
with increased cardiac afterload [13,14], the latter with
decreased coronary artery filling pressure [15], and these
mechanisms may explain the association between brachial
artery pulse pressure and increased risk of mortality.
Carotid artery diameter was also positively associated
with mortality risk after adjustment for age and sex.
Further adjustment for other cardiovascular risk factors
somewhat diminished the risk estimate, but it remained
statistically significant (Table 3, model 3), and, for reasons
similar to those noted above for pulse pressure, this risk
estimate may be somewhat overadjusted. It may at first
seem surprising that a larger carotid diameter should be
associated with increased mortality risk. Pathophysiologi-
cally, diameter enlargement may represent active remodel-
ling of the vascular wall associated with local or more
generalized atherosclerosis [16,17], a process in which
enzymatic breakdown of extracellular matrix on the one
hand and smooth muscle cell proliferation on the other are
combined in a well-programmed reorganization [31].
Alternatively or additionally, it may reflect structural
damage to cellular and extracellular matrix elements
associated with increased local arterial stiffness
[14,16,18,19]. An example of the latter is that advanced
glycation end products, whose formation is stimulated
under conditions of hyperglycaemia, may cross-link elastin
fibres resulting in increased susceptibility to rupture of
elastic lamellae, increased local stiffness and a larger
diameter [32]. Although a definite distinction between
these two processes as the underlying factor of diameter
enlargement may not be possible, our data do not support
increased local arterial stiffness as the most likely one. First
and foremost, carotid artery distensibility (and compli-
ance) coefficient, which directly reflect local stiffness, were
not significantly associated with mortality risk (Table 2).
Second, the associations of brachial pulse pressure and
carotid artery diameter on the one hand and mortality on
the other were largely independent of each other, suggest-
ing the presence of distinct underlying mechanisms. If, as
Table 3 Brachial artery pulse pressure and common carotid artery
diameter as determinants of mortality during a 6·6-year follow-up
among 140 subjects with a recent history of impaired glucose
tolerance
Independent variable Model Hazard ratio P
Brachial artery pulse
pressure
1 1·7 (1·2–2·5) 0·004
2 1·6 (1·1–2·5) 0·02
3a 1·6 (1·1–2·6) 0·03
3b 1·6 (0·9–3·1) 0·14
4 1·4 (0·9–2·1) 0·10
Common carotid artery
diameter
1 2·1 (1·3–3·3) 0·002
2 2·0 (1·3–3·3) 0·004
3a 1·8 (1·1–2·8) 0·02
3b 1·7 (1·05–2·7) 0·03
4 1·8 (1·1–2·9) 0·03
Results of proportional hazards regression analyses are shown as
hazard ratios and 95% confidence intervals per standard deviation
of the independent variables. P, probability value. Adjustments:
model 1: none (univariate); model 2: for age and sex; model 3a: as
in model 2 plus for waist-to-hip ratio, body mass index, total
cholesterol, and presence of pre-existent cardiovascular disease;
model 3b: as in model 3a plus for mean arterial pressure; model 4:
adjusted only for diameter (in pulse pressure analyses) or for pulse
pressure (in diameter analyses).
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seems likely, increased central arterial stiffness explains
why increased brachial artery pulse pressure is associated
with an adverse prognosis, then it follows that increased
arterial stiffness is a less likely explanation for the
association between carotid artery diameter and mortality
risk. We therefore favour the interpretation that carotid
artery diameter enlargement may be a response to the
atherosclerotic process and that this may explain its
association with mortality. Such diameter enlargement
can occur as a response to local atherosclerosis [17], or as a
more generalized phenomenon in response to athero-
sclerosis elsewhere [16]. We cannot distinguish between
these possibilities, because, although we avoided measur-
ing diameter at sites with mural atherosclerotic plaques, we
did not obtain an estimate of intima-media thickness as a
measure of local incipient atherosclerosis.
Regardless of their pathophysiological interpretation,
our data suggest that measurement of carotid arterial
diameter (and possibly also of brachial artery pulse
pressure) in subjects with impaired glucose tolerance
may be useful to obtain an estimate of mortality risk that
is more precise than that based on the measurement of
conventional risk factors alone, and may thus have
additional value. This may be clinically useful, because it
can help to individualize decisions on the treatment of, for
example, hypercholesterolaemia or hypertension.
The limitations ofour study mustbeconsidered.Our study
was too small to analyse associations with cardiovascular
instead of all-cause mortality. We were also unable to
establish definitively whether the association between pulse
pressure and mortality remained statistically significant after
adjustment for risk factors other than age and sex. Drop-out
from the impaired glucose tolerance cohort before the
ultrasound measurements (n  84) [19] may have caused
bias, as these subjects had a slightly more impaired glucose
homeostasis than did those who participated. However, it is
unlikely that the associations that we found would have been
different in the drop-outs as compared to the participants, as
glucose levels, either fasting or postload, were not signifi-
cantly associated with mortality in any of the analyses. A
strength of our design was that we investigated a population-
based sample of individuals with impaired glucose tolerance
[19], a condition that is known to be prevalent among the
middle-aged and elderly and to be associated with an
increased risk of mortality compared to the normal glucose-
tolerant state [3]. It is not clear, however, whether our
findings can be generalized to individuals with type 2 diabetes
or with normal glucose tolerance.
In conclusion, the results of our study show that, among
middle-aged and elderly subjects with a recent history of
impaired glucose tolerance, brachial artery pulse pressure
and common carotid artery diameter were positively
associated with risk of mortality during 6·6 years of
follow-up. These findings suggest that increased central
arterial stiffness (reflected by brachial artery pulse
pressure) and arterial remodelling (reflected by carotid
diameter enlargement) are part of the pathophysiology of
clinical atherothrombotic disease in individuals with
impaired glucose tolerance.
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